Page 1 of 1

Phase I clinical trial of i.v. ascorbic acid in advanced malignancy

Posted: Sat Aug 12, 2017 4:04 am
by Octave
Conclusions: High-dose i.v. ascorbic acid was well tolerated but failed to demonstrate anticancer activity when administered to patients with previously treated advanced malignancies.

https://academic.oup.com/annonc/article/19/11/1969/199216/Phase-I-clinical-trial-of-i-v-ascorbic-acid-in#1995524

Do you see any flaws in this study ?